A new biotechnology-based company is born in the Institute for Bioengineering of Catalonia (IBEC), member of CataloniaBio & HealthTech. The IBEC Spin-off with private participation, Vitala Technologies, will offer innovative solutions for the analysis of drugs during their development, as well as the possibility to know in advance and in a personalized way, what will be the response of a patient to a certain treatment, aiming to accelerate and optimize the identification of drugs to bring to the market.
Vitala combines innovative bioengineering technologies such as organs-on-a-chip and advanced imaging techniques, to offer unprecedented value in preclinical therapeutic compound research, as well as in the selection of the best drugs to be used in the clinic. It offers more sensitive, low-cost, and bioethical techniques than the existing ones. Among its future services, Vitala is exploring entering other markets such as the analysis of biological samples, cosmetics, ºand the agri-food market.
“The birth of this company also contributes to IBEC’s final objective: to help finding real solutions to health problems using bioengineering,” says Josep Samitier, Director of IBEC.
Comments